Insider · CIK 0001878290

Clark George C.

Reports to the SEC for 2 companies · NEW HAVEN, CT

sec.gov

Transactions

Companies

Filings

CIK

0001878290

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-27	BHVNBiohaven Ltd. · Stock Options (Right to buy)A Award	VP, Chief Accounting Officer	AAward	+50K sh	—	—	50,000
2026-01-05	BHVNBiohaven Ltd. · Restricted Share Unit AwardM Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	−2,500 sh	—	—	5,000
2026-01-05	BHVNBiohaven Ltd.F Tax Payment	VP, Chief Accounting Officer	FTax Payment	−1,117 sh	$9.93	−$11.1K	66,978
2026-01-05	BHVNBiohaven Ltd.M Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	+2,500 sh	—	—	68,095
2025-11-17	BHVNBiohaven Ltd.P Purchase	VP, Chief Accounting Officer	PPurchase	+17K sh	$8.52	+$145K	20,000
2025-01-05	BHVNBiohaven Ltd.F Tax Payment	VP, Chief Accounting Officer	FTax Payment	−1,117 sh	$38.64	−$43.2K	65,051
2025-01-05	BHVNBiohaven Ltd. · Restricted Share Unit AwardM Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	−2,500 sh	—	—	7,500
2025-01-05	BHVNBiohaven Ltd. · Restricted Share Unit AwardA Award	VP, Chief Accounting Officer	AAward	+10K sh	—	—	10,000
2025-01-05	BHVNBiohaven Ltd. · Stock Options (Right to buy)A Award	VP, Chief Accounting Officer	AAward	+30K sh	—	—	30,000
2025-01-05	BHVNBiohaven Ltd.M Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	+2,500 sh	—	—	66,168
2024-01-02	BHVNBiohaven Ltd. · Stock Options (Right to buy)A Award	VP, Chief Accounting Officer	AAward	+27.5K sh	—	—	27,500
2023-11-02	BHVNBiohaven Ltd. · Stock Options (Right to buy)A Award	VP, Chief Accounting Officer	AAward	+22.5K sh	—	—	22,500
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	VP, Chief Accounting Officer	DDisposition to Issuer	−960 sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.D Disposition to Issuer	VP, Chief Accounting Officer	DDisposition to Issuer	−4,292 sh	$148.50	−$637K	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Restricted Share Unit AwardD Disposition to Issuer	VP, Chief Accounting Officer	DDisposition to Issuer	−3,000 sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Restricted Share Unit AwardD Disposition to Issuer	VP, Chief Accounting Officer	DDisposition to Issuer	−1,000 sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Restricted Share Unit AwardD Disposition to Issuer	VP, Chief Accounting Officer	DDisposition to Issuer	−15K sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Restricted Share Unit AwardD Disposition to Issuer	VP, Chief Accounting Officer	DDisposition to Issuer	−1,750 sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Restricted Share Unit AwardD Disposition to Issuer	VP, Chief Accounting Officer	DDisposition to Issuer	−1,000 sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	VP, Chief Accounting Officer	DDisposition to Issuer	−775 sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	VP, Chief Accounting Officer	DDisposition to Issuer	−9,225 sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	VP, Chief Accounting Officer	DDisposition to Issuer	−10K sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	VP, Chief Accounting Officer	DDisposition to Issuer	−2,398 sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	VP, Chief Accounting Officer	DDisposition to Issuer	−4,602 sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	VP, Chief Accounting Officer	DDisposition to Issuer	−2,250 sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	VP, Chief Accounting Officer	DDisposition to Issuer	−1,915 sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	VP, Chief Accounting Officer	DDisposition to Issuer	−1,250 sh	—	—	0
2022-05-10	Biohaven Pharmaceutical Holding Co Ltd.M Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	+2,250 sh	$53.76	+$121K	8,265
2022-05-10	Biohaven Pharmaceutical Holding Co Ltd.S Sale	VP, Chief Accounting Officer	SSale	−4,200 sh	$141.50	−$594K	4,065
2022-05-10	Biohaven Pharmaceutical Holding Co Ltd.Employee Stock Option (right to buy)M Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	−2,250 sh	—	—	2,250
2022-01-19	Biohaven Pharmaceutical Holding Co Ltd.S Sale	VP, Chief Accounting Officer	SSale	−2,159 sh	$116.02	−$250K	10,035
2022-01-19	Biohaven Pharmaceutical Holding Co Ltd.S Sale	VP, Chief Accounting Officer	SSale	−3,196 sh	$114.93	−$367K	12,194
2022-01-19	Biohaven Pharmaceutical Holding Co Ltd.M Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	+3,750 sh	$53.76	+$202K	13,470
2022-01-19	Biohaven Pharmaceutical Holding Co Ltd.M Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	+1,920 sh	$32.42	+$62.2K	15,390
2022-01-19	Biohaven Pharmaceutical Holding Co Ltd.Employee Stock Option (right to buy)M Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	−3,750 sh	—	—	4,500
2022-01-19	Biohaven Pharmaceutical Holding Co Ltd.S Sale	VP, Chief Accounting Officer	SSale	−3,520 sh	$119.37	−$420K	6,015
2022-01-19	Biohaven Pharmaceutical Holding Co Ltd.S Sale	VP, Chief Accounting Officer	SSale	−500 sh	$118.05	−$59K	9,535
2022-01-19	Biohaven Pharmaceutical Holding Co Ltd.Employee Stock Option (right to buy)M Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	−1,920 sh	—	—	2,875
2022-01-10	Biohaven Pharmaceutical Holding Co Ltd.Restricted Share Unit AwardM Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	−1,000 sh	—	—	1,000
2022-01-10	Biohaven Pharmaceutical Holding Co Ltd.M Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	+1,000 sh	—	—	10,184
2022-01-10	Biohaven Pharmaceutical Holding Co Ltd.F Tax Payment	VP, Chief Accounting Officer	FTax Payment	−464 sh	$128.87	−$59.8K	9,720
2022-01-07	Biohaven Pharmaceutical Holding Co Ltd.M Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	+1,000 sh	—	—	9,706
2022-01-07	Biohaven Pharmaceutical Holding Co Ltd.Employee Stock Option (right to buy)A Award	VP, Chief Accounting Officer	AAward	+10K sh	—	—	10,000
2022-01-07	Biohaven Pharmaceutical Holding Co Ltd.Restricted Share Unit AwardA Award	VP, Chief Accounting Officer	AAward	+5,000 sh	—	—	5,000
2022-01-07	Biohaven Pharmaceutical Holding Co Ltd.Restricted Share Unit AwardM Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	−1,000 sh	—	—	4,000
2022-01-07	Biohaven Pharmaceutical Holding Co Ltd.F Tax Payment	VP, Chief Accounting Officer	FTax Payment	−522 sh	$128.87	−$67.3K	9,184
2022-01-06	Biohaven Pharmaceutical Holding Co Ltd.M Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	+875 sh	—	—	9,115
2022-01-06	Biohaven Pharmaceutical Holding Co Ltd.Restricted Share Unit AwardM Exercise/Conversion	VP, Chief Accounting Officer	MExercise/Conversion	−875 sh	—	—	1,750
2022-01-06	Biohaven Pharmaceutical Holding Co Ltd.F Tax Payment	VP, Chief Accounting Officer	FTax Payment	−409 sh	$123.86	−$50.7K	8,706
2021-12-20	Biohaven Pharmaceutical Holding Co Ltd.S Sale	VP, Chief Accounting Officer	SSale	−1,915 sh	$123.84	−$237K	8,240

Recent filings

Accepted (ET)
Mar 34
Clark George C.0001878290-26-000004
SEC(opens sec.gov)
Jan 74
Clark George C.0001878290-26-000002
SEC(opens sec.gov)
Nov 184
Clark George C.0001878290-25-000004
SEC(opens sec.gov)
Jan 74
Clark George C.0001935979-25-000004
SEC(opens sec.gov)
Jan 44
Clark George C.0001562180-24-000287
SEC(opens sec.gov)
Nov 64
Clark George C.0001562180-23-007578
SEC(opens sec.gov)
Oct 34
Clark George C.0001562180-22-006952
SEC(opens sec.gov)

Companies

Address

C/O BIOHAVEN LTD. 215 CHURCH STREET

NEW HAVEN, CT, 06510